US Patent Issued to CARTEXELL on April 14 for "Anti-L1CAM antibody or antigen-binding fragment thereof and chimeric antigen receptor comprising same" (South Korean Inventors)

Posted On: 2026-04-15

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,776, issued on April 14, was assigned to CARTEXELL INC. (Seoul, South Korea). "Anti-L1CAM antibody or antigen-binding fragment thereof and... Read More

US Patent Issued to Novartis, Immutep on April 14 for "Combination therapies comprising antibody molecules to LAG-3" (American, French Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,777, issued on April 14, was assigned to Novartis AG (Basel, Switzerland) and Immutep S.A.S. (Orsay, France). "Combination therapies compr... Read More

US Patent Issued to The Research Foundation for The State University of New York, The Regents of the University of California on April 14 for "Rage antibodies, fragments and uses thereof" (New York, California Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,778, issued on April 14, was assigned to The Research Foundation for The State University of New York (Amherst, N.Y.) and The Regents of th... Read More

US Patent Issued to MACROGENICS on April 14 for "LAG-3-binding molecules and methods of use thereof" (Maryland, California Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,779, issued on April 14, was assigned to MACROGENICS INC. (Rockville, Md.). "LAG-3-binding molecules and methods of use thereof" was inven... Read More

US Patent Issued to Regeneron Pharmaceuticals on April 14 for "Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof" (New York Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,780, issued on April 14, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Anti-CD3 antibodies, bispecific antigen-bindin... Read More

US Patent Issued to BIOTHEUS on April 14 for "Anti-PD-L1 and PD-L2 antibody and derivatives and use thereof" (Chinese Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,782, issued on April 14, was assigned to BIOTHEUS INC. (Zhuhai, China). "Anti-PD-L1 and PD-L2 antibody and derivatives and use thereof" wa... Read More

US Patent Issued to Regeneron Pharmaceuticals on April 14 for "Anti-New York esophageal squamous cell carcinoma 1 (NY-ESO-1) antigen-binding proteins and methods of use thereof" (New York Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,783, issued on April 14, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Anti-New York esophageal squamous cell carcino... Read More

US Patent Issued to Millennium Pharmaceuticals on April 14 for "Anti-Clec12A antibodies and uses thereof" (Massachusetts Inventor)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,784, issued on April 14, was assigned to Millennium Pharmaceuticals Inc. (Cambridge, Mass.). "Anti-Clec12A antibodies and uses thereof" wa... Read More

US Patent Issued to Antlera Therapeutics on April 14 for "Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene" (Canadian Inventors)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,785, issued on April 14, was assigned to Antlera Therapeutics Inc. (Foster City, Calif.). "Method of screening for compounds that inhibit ... Read More

US Patent Issued to R.G.C.C. Holdings on April 14 for "C-met and TMX2 antibodies" (Swiss Inventor)

Posted On: 2026-04-15

Government News US Fed News Patentwipo

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,786, issued on April 14, was assigned to R.G.C.C. Holdings AG (Zug, Switzerland). "C-met and TMX2 antibodies" was invented by Ioannis Papa... Read More

Exclusive

Category

Source

Publication

Byline

Location

US Patent Issued to CARTEXELL on April 14 for "Anti-L1CAM antibody or antigen-binding fragment thereof and chimeric antigen receptor comprising same" (South Korean Inventors)

US Patent Issued to Novartis, Immutep on April 14 for "Combination therapies comprising antibody molecules to LAG-3" (American, French Inventors)

US Patent Issued to The Research Foundation for The State University of New York, The Regents of the University of California on April 14 for "Rage antibodies, fragments and uses thereof" (New York, California Inventors)

US Patent Issued to MACROGENICS on April 14 for "LAG-3-binding molecules and methods of use thereof" (Maryland, California Inventors)

US Patent Issued to Regeneron Pharmaceuticals on April 14 for "Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof" (New York Inventors)

US Patent Issued to BIOTHEUS on April 14 for "Anti-PD-L1 and PD-L2 antibody and derivatives and use thereof" (Chinese Inventors)

US Patent Issued to Regeneron Pharmaceuticals on April 14 for "Anti-New York esophageal squamous cell carcinoma 1 (NY-ESO-1) antigen-binding proteins and methods of use thereof" (New York Inventors)

US Patent Issued to Millennium Pharmaceuticals on April 14 for "Anti-Clec12A antibodies and uses thereof" (Massachusetts Inventor)

US Patent Issued to Antlera Therapeutics on April 14 for "Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene" (Canadian Inventors)

US Patent Issued to R.G.C.C. Holdings on April 14 for "C-met and TMX2 antibodies" (Swiss Inventor)